Analysts expect Mirum Pharmaceuticals, Inc. to report revenue of 174.77 M for Q4 26, against a range of 159.80 M to 189.73 M. The most recent reported quarter, Q3 26, came in at 185.72 M, a 7.8% beat against the 172.24 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 99.41 M | 111.58 M | 127.78 M | 133.01 M | 148.93 M | 159.90 M | 176.20 M | 185.72 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 106.14 M | 100.39 M | 115.41 M | 134.07 M | 143.96 M | 167.44 M | 180.82 M | 184.95 M | 189.73 M | 213.09 M | 221.28 M | 208.12 M | 253.78 M | 246.39 M | 276.47 M | 299.99 M | |||||||||
| Low Estimate | 98.41 M | 86.44 M | 94.63 M | 113.97 M | 135.33 M | 142.28 M | 162.48 M | 159.54 M | 159.80 M | 185.65 M | 200.18 M | 191.24 M | 218.46 M | 217.61 M | 226.41 M | 252.85 M | |||||||||
| Consensus Estimate | 102.27 M | 93.41 M | 105.02 M | 124.02 M | 139.65 M | 154.86 M | 171.65 M | 172.24 M | 174.77 M | 199.37 M | 210.73 M | 199.68 M | 236.12 M | 232.00 M | 251.44 M | 276.42 M |
Analysts expect Mirum Pharmaceuticals, Inc. to report earnings per share of -0.54 for Q4 26, against a range of -0.57 to -0.51. The most recent reported quarter, Q3 26, came in at -0.87, a 70.6% miss against the -0.51 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.49 | -0.30 | -0.12 | 0.05 | -0.10 | -13.43 | -1.06 | -0.87 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.24 | -0.33 | -0.30 | -0.13 | 0.06 | -0.33 | -0.73 | -0.46 | -0.51 | -0.36 | -0.28 | -0.25 | 1.06 | -1.03 | 1.29 | 0.70 | |||||||||
| Low Estimate | -0.26 | -0.35 | -0.32 | -0.15 | 0.06 | -0.37 | -0.83 | -0.56 | -0.57 | -0.40 | -0.30 | -0.27 | 0.94 | -1.25 | 1.19 | 0.62 | |||||||||
| Consensus Estimate | -0.25 | -0.34 | -0.31 | -0.14 | 0.06 | -0.35 | -0.78 | -0.51 | -0.54 | -0.38 | -0.29 | -0.26 | 1.00 | -1.14 | 1.24 | 0.66 |
Pull Wall Street consensus for Mirum Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MIRM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MIRM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MIRM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();